ZA96399B - 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones - Google Patents

9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones

Info

Publication number
ZA96399B
ZA96399B ZA96399A ZA96399A ZA96399B ZA 96399 B ZA96399 B ZA 96399B ZA 96399 A ZA96399 A ZA 96399A ZA 96399 A ZA96399 A ZA 96399A ZA 96399 B ZA96399 B ZA 96399B
Authority
ZA
South Africa
Prior art keywords
alkoxyphenyl
purin
ones
substituted
Prior art date
Application number
ZA96399A
Other languages
English (en)
Inventor
Ulrich Niewoehner
Erwin Bischoff
Helmuth Schuetz
Elisabeth Perzborn
Matthias Schramm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA96399B publication Critical patent/ZA96399B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA96399A 1995-01-19 1996-01-18 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones ZA96399B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (de) 1995-01-19 1995-01-19 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one

Publications (1)

Publication Number Publication Date
ZA96399B true ZA96399B (en) 1996-08-14

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96399A ZA96399B (en) 1995-01-19 1996-01-18 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones

Country Status (30)

Country Link
US (1) US5866571A (fr)
EP (1) EP0722943A1 (fr)
JP (1) JPH08231546A (fr)
KR (1) KR960029335A (fr)
CN (1) CN1138583A (fr)
AR (1) AR002704A1 (fr)
AU (1) AU4097796A (fr)
BG (1) BG61729B1 (fr)
BR (1) BR9600149A (fr)
CA (1) CA2167349A1 (fr)
CO (1) CO4700524A1 (fr)
CZ (1) CZ16896A3 (fr)
DE (1) DE19501480A1 (fr)
EE (1) EE9600020A (fr)
FI (1) FI960226A7 (fr)
HR (1) HRP960009A2 (fr)
HU (1) HUP9600107A3 (fr)
IL (1) IL116771A (fr)
MA (1) MA23779A1 (fr)
NO (1) NO960221L (fr)
NZ (1) NZ280829A (fr)
PE (1) PE10597A1 (fr)
PL (1) PL312353A1 (fr)
SG (1) SG47379A1 (fr)
SK (1) SK7696A3 (fr)
SV (1) SV1996000004A (fr)
TN (1) TNSN96005A1 (fr)
TR (1) TR199600701A2 (fr)
YU (1) YU2896A (fr)
ZA (1) ZA96399B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (de) * 1998-08-24 2000-03-02 Bayer Ag 9-Dialkylaminopurinon-derivate
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
ES2381862T3 (es) * 2000-09-06 2012-06-01 Mitsubishi Tanabe Pharma Corporation Preparaciones para administración por vía oral
NZ527585A (en) * 2001-02-15 2005-04-29 Tanabe Seiyaku Co Tablets quickly disintegrated in oral cavity
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2003053975A1 (fr) * 2001-12-13 2003-07-03 Daiichi Suntory Pharma Co., Ltd. Derives de pyrazolopyrimidinone possedant une activite inhibitrice de pde7
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
AU2003226149A1 (en) * 2002-04-05 2003-10-27 Merck & Co., Inc. Substituted aryl amides
WO2015200177A1 (fr) 2014-06-23 2015-12-30 Celgene Corporation Utilisation d'aprémilast pour le traitement d'une maladie hépatique ou d'une anomalie de la fonction hépatique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (fr) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Derives de purinone utilises comme bronchodilatateurs,vasodilatateurs et agents anti-allergiques
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
PE10597A1 (es) 1997-06-13
NO960221D0 (no) 1996-01-18
MA23779A1 (fr) 1996-10-01
NZ280829A (en) 1998-04-27
YU2896A (sh) 1999-03-04
CO4700524A1 (es) 1998-12-29
EE9600020A (et) 1996-08-15
HRP960009A2 (en) 1997-12-31
JPH08231546A (ja) 1996-09-10
EP0722943A1 (fr) 1996-07-24
AR002704A1 (es) 1998-04-29
IL116771A (en) 1999-06-20
PL312353A1 (en) 1996-07-22
CA2167349A1 (fr) 1996-07-20
NO960221L (no) 1996-07-22
DE19501480A1 (de) 1996-07-25
SV1996000004A (es) 1997-02-19
FI960226A7 (fi) 1996-07-20
BR9600149A (pt) 1998-01-06
HU9600107D0 (en) 1996-03-28
FI960226A0 (fi) 1996-01-17
SG47379A1 (en) 1998-04-17
TNSN96005A1 (en) 2005-03-15
CZ16896A3 (en) 1996-08-14
IL116771A0 (en) 1996-05-14
SK7696A3 (en) 1996-08-07
KR960029335A (ko) 1996-08-17
HUP9600107A3 (en) 1999-06-28
AU4097796A (en) 1996-07-25
TR199600701A2 (tr) 1996-08-21
HUP9600107A2 (en) 1997-05-28
BG61729B1 (bg) 1998-04-30
CN1138583A (zh) 1996-12-25
BG100291A (bg) 1996-07-31
US5866571A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
DE69618179D1 (en) Arylsulfonylaminohydroxamsäurederivate
DE69513693D1 (en) Positions-servo-system
DE69606427D1 (en) Hydroformylierungsverfahren
SG47379A1 (en) 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
DE69610843D1 (en) Hydroformylierungsverfahren
DE69516545D1 (en) Polyacetalharzzusammensetzung
DE59608164D1 (en) Cyclohexenonoximether-metallsalze
GB2298128B (en) Mopheads
DE59602030D1 (en) Zellige polyurethan-elastomere
GB9502654D0 (en) Dartboards
DE69611833D1 (en) Carbonylierungsreaktionen
GB9512946D0 (en) Eyescare
DE59604913D1 (en) Carbonylverbindungen
GB9516224D0 (en) Slow-fall
GB9509675D0 (en) Firelighting
GB9504268D0 (en) Water-skis
GB9514154D0 (en) Drawing aid
GB9505839D0 (en) Drawing aid
GB9503773D0 (en) Polyflutes
GB9500801D0 (en) Quinny
GB9508653D0 (en) Suspend-a-spec
GB9502420D0 (en) Hyperball
GB9506911D0 (en) Drivers-keyboard
GB9516859D0 (en) Bed-box
GB9511470D0 (en) Kerbing